Can WR-2721 be improved upon?
Brown
D Q
DQ
Department of Radiation Therapy, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
Graham
W J
WJ
MacKenzie
L J
LJ
Pittock
J W
JW
Shaw
L M
LM
D004999:Amifostine / Q000627:therapeutic use* / Q000633:toxicity; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D006413:Hematopoietic System / Q000187:drug effects; D009381:Neoplasms, Radiation-Induced / Q000517:prevention & control; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D011833:Radiation Injuries, Experimental / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000627:therapeutic use* / Q000633:toxicity
D009946:Organothiophosphorus Compounds; D011837:Radiation-Protective Agents; D004999:Amifostine